Acknowledgement
Grant : Environmental Research Center Project
Supported by : Ministry of Environment
References
- Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704
- Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007;120:S94-138 https://doi.org/10.1016/j.jaci.2007.09.029
- Allen DB. Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Adv Pediatr 2006;53:101-10 https://doi.org/10.1016/j.yapd.2006.04.006
- Allen DB. Systemic effects of inhaled corticosteroids in children. Curr Opin Pediatr 2004;16:440-4 https://doi.org/10.1097/01.mop.0000129597.48138.e7
- Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med 2006;100:1307-17 https://doi.org/10.1016/j.rmed.2005.11.020
- Allen DB, Bielory L, Derendorf H, Dluhy R, Colice GL, Szefler SJ. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol 2003;112:S1-40 https://doi.org/10.1016/S0091-6749(03)01859-1
- Griffiths AL, Sim D, Strauss B, Rodda C, Armstrong D, Freezer N. Effect of high-dose fluticasone propionate on bone density and metabolism in children with asthma. Pediatr Pulmonol 2004;37:116-21 https://doi.org/10.1002/ppul.10396
- Roux C, Kolta S, Desfougeres JL, Minini P, Bidat E. Long- term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics 2003;111:e706-13 https://doi.org/10.1542/peds.111.6.e706
- Allen HD, Thong IG, Clifton-Bligh P, Holmes S, Nery L, Wilson KB. Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol 2000;29:188-93 https://doi.org/10.1002/(SICI)1099-0496(200003)29:3<188::AID-PPUL6>3.0.CO;2-K
- Kelly HW, Van Natta ML, Covar RA, Tonascia J, Green RP, Strunk RC; CAMP Research Group. Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood asthma management program (CAMP) study. Pediatrics 2008;122: e53-61 https://doi.org/10.1542/peds.2007-3381
- Bahceciler NN, Sezgin G, Nursoy MA, Barlan IB, Basaran MM. Inhaled corticosteroids and bone density of children with asthma. J Asthma 2002;39:151-7 https://doi.org/10.1081/JAS-120002196
- Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-7 https://doi.org/10.1016/0091-6749(75)90107-4
- National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma expert panel. Report 2. Bethesda, MD: US Dept of Health and Human Services, 1997. NIH publication 97-4051
- Harris M, Hauser S, Nguyen TV, Kelly PJ, Rodda C, Morton J, et al. Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment. J Paediatr Child Health 2001;37:67-71 https://doi.org/10.1046/j.1440-1754.2001.00628.x
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129
- Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-82 https://doi.org/10.1172/JCI2799
- Canalis E. Mechanisms of glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 2003;15:454-7 https://doi.org/10.1097/00002281-200307000-00013
- Agertoft L, Pedersen S. Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care Med 1998;157:178-83
- The Childhood Asthma Management Program Research Group (CAMP study). Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343: 1054-63 https://doi.org/10.1056/NEJM200010123431501
- Jones G, Ponsonby AL, Smith BJ, Carmichael A. Asthma, inhaled corticosteroid use, and bone mass in prepubertal children. J Asthma 2000;37:603-11 https://doi.org/10.3109/02770900009090816
- Kelly HW, Nelson HS. Potential adverse effects of the inhaled corticosteroids. J Allergy Clin Immunol 2003;112:469-78 https://doi.org/10.1016/S0091-6749(03)01870-0
- Sivri A, Coplu L. Effect of the long-term use of inhaled corticosteroids on bone mineral density in asthmatic women. Respirology 2001;6:131-4 https://doi.org/10.1046/j.1440-1843.2001.00323.x
- Mainz JG, Sauner D, Malich A, John S, Beyermann H, Mentzel HJ, et al. Cross-sectional study on bone density- related sonographic parameters in children with asthma: correlation to therapy with inhaled corticosteroids and disease severity. J Bone Miner Metab 2008;26:485-92 https://doi.org/10.1007/s00774-008-0860-6
- Akil I, Yuksel H, Urk V, Var A, Onur E. Biochemical markers of bone metabolism and calciuria with inhaled budesonide therapy. Pediatr Nephrol 2004;19:511-5 https://doi.org/10.1007/s00467-004-1418-z
- Chay OM, Goh A, Lim WH, Leong KH, Lou J. Effects of inhaled corticosteroid on bone turnover in children with bronchial asthma. Respirology 1999;4:63-7 https://doi.org/10.1046/j.1440-1843.1999.00148.x
- Hughes JA, Conry BG, Male SM, Eastell R. One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density. Thorax 1999;54:223-9 https://doi.org/10.1136/thx.54.3.223
- Woodcock A. Effects of inhaled corticosteroids on bone density and metabolism. J Allergy Clin Immunol 1998;101: S456-9 https://doi.org/10.1016/S0091-6749(98)70159-9